Primary sclerosing cholangitis is a disease where the tubes that transfer bile between the liver, gallbladder, and small ...
In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology published a consensus on primary ...
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.
Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).
Please provide your email address to receive an email when new articles are posted on . Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated ...
COUR Pharmaceuticals’ emerging platform reprograms the immune system to address the root causes of autoimmune diseases.
--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary ...
Primary sclerosing cholangitis (PSC) is a chronic autoimmune disease with inflammation and stricture formation in the bile ducts inside the liver and/or in the extrahepatic bile duct which drains into ...